LITTLECHILD JOHN W

CIK 000101346915 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001013469

Recent Transactions

50 trades

Award
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Stock Option (Right to Buy)
2020-03-02+20,000→ 20,000 total
Award
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Stock Option (Right to Buy)
2019-06-11+10,000→ 10,000 total
Award
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Stock Option (Right to Buy)
2019-01-01+7,500→ 7,500 total
Other
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Warrant (Right to Buy)
2018-07-30+2,137→ 2,137 total
Award
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Stock Option (Right to Buy)
2018-04-18+11,250→ 11,250 total
Award
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Stock Option (Right to Buy)
2017-01-23+15,000→ 15,000 total
Award
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Stock Option (Right to Buy)
2017-01-23+11,000→ 11,000 total
Sale
GLOBEIMMUNE INC
Common Stock
2016-02-19$1.39/sh−5,000→ 554,267 total
Sale
GLOBEIMMUNE INC
Common Stock
2016-02-18$1.40/sh−5,000→ 559,267 total
Conversion
KINETA, INC./DE
Series B Convertible Redeemable Preferred Stock
2016-02-17−2,319,750→ 0 total
Other
KINETA, INC./DE
Common Stock Warrant (Right to Buy)
2016-02-17+14,800→ 14,800 total
Sale
GLOBEIMMUNE INC
Common Stock
2016-02-17$1.53/sh−5,000→ 564,267 total
Other
KINETA, INC./DE
Series A Convertible Preferred Warrant (Right to Buy)
2016-02-17−160,000→ 0 total
Purchase
KINETA, INC./DE
Common Stock
2016-02-17$8.00/sh+375,000→ 2,149,295 total
Conversion
KINETA, INC./DE
Series A Convertible Redeemable Preferred Stock
2016-02-17−11,600,000→ 0 total
Conversion
KINETA, INC./DE
Common Stock
2016-02-17+1,774,295→ 1,774,295 total
Sale
GLOBEIMMUNE INC
Common Stock
2016-02-16$1.51/sh−5,000→ 569,267 total
Sale
GLOBEIMMUNE INC
Common Stock
2016-02-12$1.59/sh−5,000→ 574,267 total
Sale
GLOBEIMMUNE INC
Common Stock
2016-02-11$1.72/sh−5,000→ 579,267 total
Conversion
GLOBEIMMUNE INC
Common Stock
2014-07-08+188,096→ 268,629 total
Conversion
GLOBEIMMUNE INC
Common Stock
2014-07-08+123,574→ 392,203 total
Conversion
GLOBEIMMUNE INC
Common Stock
2014-07-08+2,064→ 394,267 total
Purchase
GLOBEIMMUNE INC
Common Stock
2014-07-08$10.00/sh+190,000→ 584,267 total
Conversion
GLOBEIMMUNE INC
Series A Convertible Preferred Stock
2014-07-08−2,528,000→ 0 total
Conversion
GLOBEIMMUNE INC
Series C Convertible Preferred Stock
2014-07-08−3,879,015→ 0 total
Conversion
GLOBEIMMUNE INC
Common Stock
2014-07-08+80,533→ 80,533 total
Conversion
GLOBEIMMUNE INC
Series B Convertible Preferred Stock
2014-07-08−5,904,335→ 0 total
Conversion
GLOBEIMMUNE INC
Series E Convertible Preferred Stock
2014-07-08−64,809→ 0 total
Conversion
TREVENA INC
Common Stock
2014-02-05+967,741→ 967,741 total
Conversion
TREVENA INC
Series B Preferred Stock
2014-02-05−4,200,000→ 0 total
Conversion
TREVENA INC
Series C Preferred Stock
2014-02-05−3,125,000→ 0 total
Conversion
TREVENA INC
Common Stock
2014-02-05+504,033→ 2,149,193 total
Purchase
TREVENA INC
Common Stock
2014-02-05$7.00/sh+297,058→ 2,446,251 total
Conversion
TREVENA INC
Series A Preferred Stock
2014-02-05−6,000,000→ 0 total
Conversion
TREVENA INC
Common Stock
2014-02-05+677,419→ 1,645,160 total
Conversion
TETRALOGIC PHARMACEUTICALS Corp
Notes
2013-12-17→ 0 total
Conversion
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2013-12-17$7.00/sh+267,535→ 1,873,003 total
Conversion
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2013-12-17+438,453→ 1,092,047 total
Conversion
TETRALOGIC PHARMACEUTICALS Corp
Series B Preferred Stock
2013-12-17−7,453,704→ 0 total
Conversion
TETRALOGIC PHARMACEUTICALS Corp
Preferred Stock Warrant
2013-12-17→ 0 total
Conversion
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2013-12-17+506,086→ 1,598,133 total
Conversion
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2013-12-17+653,594→ 653,594 total
Purchase
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2013-12-17$7.00/sh+713,463→ 2,586,466 total
Conversion
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2013-12-17$6.40/sh+7,335→ 1,605,468 total
Conversion
TETRALOGIC PHARMACEUTICALS Corp
Series A Preferred Stock
2013-12-17−5,000,000→ 0 total
Conversion
TETRALOGIC PHARMACEUTICALS Corp
Series C Preferred Stock
2013-12-17−8,603,477→ 0 total
Purchase
Radius Health, Inc.
Series A-1 Preferred Stock
2011-12-14$81.42/sh+19,651→ 58,953 total
Purchase
Radius Health, Inc.
Series A-1 Preferred Stock
2011-11-18$81.42/sh+19,651→ 39,302 total
Conversion
Altimmune, Inc.$ALT
Common Stock
2010-11-03$2.54/sh+935,814→ 4,253,057 total
Conversion
Altimmune, Inc.$ALT
10% Convertible Note
2010-11-03−935,814→ 0 total

Companies

Recent Filings

Address

55 CAMBRIDGE PARKWAY SUITE 301

CAMBRIDGE, MA, 02142

View on SEC.gov